Manufacturing
Central Manufacturing Group
CMG Manufacturing Strategy and Excellence
The 4IR CoE Manager supports the manufacturing digital transformation agenda by translating strategy into scalable initiatives, strengthening governance, building capabilities, and enabling effective adoption of digital, automation, and analytics solutions. The role collaborates with site teams, central functions, and external partners to deliver sustainable business outcomes.
Define the digital transformation roadmap; implement and scale high-value solutions; improve process and system performance; strengthen governance; manage stakeholders and partners; and promote the adoption of emerging technologies.
Assess business impact, report progress, and improve the sustainability and adoption of implemented solutions.
Understand manufacturing priorities and stakeholder needs; identify and evaluate improvement opportunities based on business value, feasibility, complexity, and user requirements; develop implementation roadmaps, governance models, data strategies, and clear accountability; and align initiatives with the organisation’s operating and excellence frameworks.
Partner with stakeholders to define business problems, quantify expected benefits, establish success measures, document requirements, evaluate solution options, and manage delivery through an appropriate project methodology. Ensure solutions are implemented securely, effectively, and in line with agreed scope, timelines, and business outcomes.
Establish governance mechanisms to monitor delivery, adoption, benefits, risks, and sustainability of digital initiatives. Conduct periodic reviews with leadership and site teams, use maturity assessments to identify gaps, and incorporate user feedback and lessons learned into continuous improvement.
Identify and engage suitable technology partners, maintain effective communication between business and technical stakeholders, and coordinate required solution, security, compliance, and implementation assessments before deployment.
Evaluate and deploy appropriate digital, automation, analytics, and emerging technologies to improve productivity, quality, reliability, compliance, and user experience. Support the development of connected and increasingly automated operations by identifying suitable opportunities, technologies, and implementation partners.
Build digital capability across teams by developing learning materials, conducting workshops, coaching initiative owners and site representatives, and supporting end users in the effective adoption and sustained use of digital and automation solutions.
Identifying correct vendor/partner for digital transformation initiatives.
Defining/Building solution logic for digital initiatives.
Inputs on escalations encountered by ongoing projects
Existing Digital Initiatives redefining solution logic
Level 0 to Level 6 Data transfer strategy and implementation.
On Technology adoption
Bachelor’s degree in engineering, technology, science, Pharmacy or a related discipline; a postgraduate qualification in business, operations, or technology is preferred.
At least five years of relevant experience in digital transformation, industrial automation, analytics, technology implementation, or operational improvement within manufacturing or a comparable industry.

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years.
Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms.
Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients.
Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement.
An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.